Potassium iodide therapy may not impair efficacy of radioiodine therapy for Graves hyperthyroidism if discontinued 2 weeks before administration of I-131

Conclusions: Pretreatment by KI does not impair therapeutic efficacy of RAI for GH if the drug is discontinued 2 weeks before administration of I-131 and is combined with low iodine diet for one week . Thus, pretreatment with KI may be feasible for patients with GH who are to undergo RAI.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Thyroid and Para-Thyroid Source Type: research